Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT07413068Recruiting

Treatment Outcomes and Complications of Three Therapeutic Approaches for Concomitant Choledocholithiasis and Cholecystolithiasis

Role: collaborator

NCT07495111Not ApplicableRecruiting

Prophylactic PS Placement to Prevent Pancreatitis After Endoscopic Transpapillary GPC for Cholelithiasis With Concomitant Choledocholithiasis

Role: collaborator

NCT07444099Not ApplicableEnrolling By Invitation

Early Postoperative Intervention in Gastric Cancer Patients

Role: collaborator

NCT06285734Recruiting

Clinical Characteristics of Small Intestinal Bacterial Overgrowth in Individuals with Abdominal Distention

Role: collaborator

NCT04044066Unknown

Biomarker-based Prognostic Assessment

Role: collaborator

NCT03510832Unknown

Evaluation of Antithrombotic STrategies in STEMI Patients in China

Role: collaborator

NCT02536677Completed

The Evaluation and Management of Patients With Acute ChesT Pain in China

Role: collaborator

NCT02985372Phase 3Unknown

Decitabine in Combination With Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia

Role: collaborator

NCT01875484Completed

Circulating miR-126 as a Novel Biomarker for Post Myocardial Infarction Remodeling

Role: collaborator

All 9 trials loaded